Introduction
Angiosarcoma is a neoplasm of an endothelial origin, which could arise from blood or lymphatic vessels, respectively hemangiosarcoma or lymphosarcoma. They account for only 0.1% of adult malignancies and represent 1-2% of all soft tissue sarcomas in humans [1] . Most tumours are malignant and readily give distant metastases because they are composed of rapidly proliferating and extensively infiltrating anaplastic cells. They can occur in any organ of the body and the most common form is a cutaneous angiosarcoma [2] . We report a PET-CT study of a rare case of cardiac angiosarcoma, which was initially misdiagnosed as heart inflammation.
Case report
The 30 year old male with heart angiosarcoma was referred for PET-CT with 18FDG study. The patient had had no significant medical history and at the beginning was hospitalised because of a continuos pain in the pericardial region, initially misdiagnosed as pericarditis. The performed CAT scan showed pathological mass in the right atrium. The patient was subsequently subjected 
Discussion
There are only few case reports concerning PET-CT with 18FDG in cardiac angiosarcoma. They are proving its usefulness in assessing malignant potential of the tumour mass and exploration for distant metastases in primary diagnosis together with metabolic response to and detection of local recurrence after applied therapy [5] [6] [7] [8] . In the presented case PET-CT with 18FDG depicted persisted high metabolic activity in the tumour mass despite three courses of adjuvant chemotherapy and metabolically active metastases in the skeleton, not visible on previously scheduled imaging studies.
Conclusion
The PET-CT study with 18FDG could be of great value for angiosarcoma staging and predicting of the metabolic response to the applied chemotherapy regimen. B. Combined PET-CT studies; C. CT study
